# clm_BEDA44B8703A

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: quarterly_research_and_development  
value: 523,902,000 United States dollar  
valid_from: 2013-06-30  
valid_to: 2013-09-30  
published: 2013-08-01  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_C46B94F27B3E  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences quarterly research and development: 523,902,000 United States dollar", as of 2013-06-30 (until 2013-09-30). Claim clm_BEDA44B8703A, https://asof.is/claim/clm_BEDA44B8703A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209513000038/0000882095-13-000038-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2013, filed 2013-08-01  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209513000038/0000882095-13-000038-index.htm (primary, SEC EDGAR 10-Q Q2 FY2013, published 2013-08-01)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | quarterly_research_and_development | 497,632,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_BEDA44B8703A](/claim/clm_BEDA44B8703A.md) | [clm_4716BEA47C18](/claim/clm_4716BEA47C18.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.